Circulating Tumour DNA To Monitor Treatment Response And Resistance In Chronic Lymphocytic Leukaemia
Funder
National Health and Medical Research Council
Funding Amount
$876,950.00
Summary
Many cancers shed small amounts of DNA (ctDNA) into the patient’s bloodstream and recent advances in genomic technologies now allow levels of ctDNA to be accurately measured in the blood. Changes in ctDNA levels have potential to be used as specific markers of disease progression and/or response to cancer therapy. This project will evaluate if ctDNA can be used to monitor treatment responses and individualise treatment decisions in patients with chronic lymphocytic leukaemia.
Molecular Characterisation Of Early Precursor Lesions Of A Novel Ñserrated Pathwayî Of Colorectal Cancer Using Gene Expression And Proteomics.
Funder
National Health and Medical Research Council
Funding Amount
$318,338.00
Summary
In Australia, CRC is the second highest cause of all cancer-related deaths. If detected early, CRC has a high success rate of cure, but a percentage of precursor lesions escape detection and show aggressive clinical behaviour to progress to CRC. These are difficult to diagnosis with existing technologies. We aim to understand the biology behind sessile serrated adenoma pathways and hence enhance early detection, diagnosis and treatments strategies.
A Randomised Clinical Trial Of Physical Activity To Delay The Progression Of Cerebrovascular Pathology
Funder
National Health and Medical Research Council
Funding Amount
$654,613.00
Summary
The aim of this randomised clinical trial is to establish whether a 24 months physical activity (PA) program for older adults with memory problems can delay the progression of damage to the blood vessel system in the brain, measured on an MRI scan. It also will investigate whether cognition, mood, quality of life, functional level, fitness and biological markers will improve with the intervention. If successful this PA program could become part of clinical care for adults at risk of dementia.
Patterns, Pathways And Price Of Developing Disparities In Cardiovascular And Respiratory Health By Age 11-12 Years: The Longitudinal Study Of Australian Children
Funder
National Health and Medical Research Council
Funding Amount
$3,290,912.00
Summary
Cardiovascular and lower respiratory diseases are leading causes of death, show marked social gradients, and have origins in early life. We will measure cardiorespiratory health at age 11-12 years in the national Longitudinal Study of Australian Children. Combined with rich existing psychosocial and health data spanning the entire first decade, we will explore early-life mechanisms underlying emerging patterns of social disparity and their potentially-avoidable cost – evidence that is essential ....Cardiovascular and lower respiratory diseases are leading causes of death, show marked social gradients, and have origins in early life. We will measure cardiorespiratory health at age 11-12 years in the national Longitudinal Study of Australian Children. Combined with rich existing psychosocial and health data spanning the entire first decade, we will explore early-life mechanisms underlying emerging patterns of social disparity and their potentially-avoidable cost – evidence that is essential to develop new intervention strategies.Read moreRead less